Accord Healthcare, Inc. recalls Levothyroxine Sodium Tablets
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range.
- Products
-
- Levothyroxine Sodium Tablets
- Company
- Accord Healthcare, Inc.
- Where it was sold
-
Nationwide in the US
Nationwide
- Units affected
- 54,432 bottles
- About this recall
- Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 90 Tablets per bottle, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-450-15.